Related Experiment Video
Updated: Aug 9, 2026
10:03
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
Rotavirus Vaccines: Current Controversies and Future Directions
1Division of Immunologic and Infectious Diseases, The Children's Hospital of Philadelphia, 34th Street and Civic Center Boulevard, Philadelphia, PA 19104, USA. coffin@email.chop.edu.
Current Infectious Disease Reports
|November 30, 2000
Summary
A rotavirus vaccine, crucial for preventing pediatric gastroenteritis, was recalled due to severe gastrointestinal side effects shortly after its US market introduction.
Area of Science:
- Virology
- Pediatric Gastroenterology
- Vaccinology
Background:
- Rotaviruses are a primary cause of severe gastroenteritis in children globally.
- The development of an effective rotavirus vaccine is a significant public health priority.
Purpose of the Study:
- To review the necessity of a rotavirus vaccine.
- To discuss the development of the initial rotavirus vaccine.
- To examine the safety concerns leading to the vaccine's market withdrawal.
Main Methods:
- Literature review of rotavirus epidemiology.
- Analysis of the historical development of the first rotavirus vaccine.
- Examination of post-licensure safety surveillance data.
Main Results:
- The first rotavirus vaccine was licensed in the US in August 1998.
- The vaccine was withdrawn 14 months later due to serious gastrointestinal side effects.
- Safety issues necessitated the recall, highlighting challenges in vaccine development.
Conclusions:
- The initial rotavirus vaccine demonstrated safety concerns requiring market withdrawal.
- Further research and development are essential for a safe and effective rotavirus vaccine.
- Understanding vaccine safety is critical for pediatric public health initiatives.
Related Concept Videos
01:51Vaccinations
Overview
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:17Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...